E.U. Targets Boehringer For Misuse Of Patent System
Antitrust proceedings have been initiated against German drug maker Boehringer AG and its subsidiaries for allegedly misusing the patent system to eliminate competition in the market for lung disease drugs, the...To view the full article, register now.
Already a subscriber? Click here to view full article